key: cord-0647088-u5s5heqm
authors: Dempsey, Walter
title: The Hypothesis of Testing: Paradoxes arising out of reported coronavirus case-counts
date: 2020-05-21
journal: nan
DOI: nan
sha: 6bb3415fd68ffd13867cd7944b70a5c83c42f2f6
doc_id: 647088
cord_uid: u5s5heqm

Coronavirus case-count data has influenced government policies and drives most epidemiological forecasts. Limited testing is cited as the key driver behind minimal information on the COVID-19 pandemic. While expanded testing is laudable, measurement error and selection bias are the two greatest problems limiting our understanding of the COVID-19 pandemic; neither can be fully addressed by increased testing capacity. In this paper, we demonstrate their impact on estimation of point prevalence and the effective reproduction number. We show that estimates based on the millions of molecular tests in the US has the same mean square error as a small simple random sample. To address this, a procedure is presented that combines case-count data and random samples over time to estimate selection propensities based on key covariate information. We then combine these selection propensities with epidemiological forecast models to construct a doubly robust estimation method that accounts for both measurement-error and selection bias. This method is then applied to estimate Indiana's prevalence using case-count, hospitalization, and death data with demographic information, a statewide random molecular sample collected from April 25--29th, and Facebook's COVID-19 symptom survey. We end with a series of recommendations based on the proposed methodology.

The World Health Organization has declared the coronavirus disease 2019 (COVID-19) a public health emergency. As of July 29th, 2021, over 196 million cases have been confirmed worldwide with 34.8 million cases and over 612 thousand confirmed deaths across the United States. This pandemic has become the focal point of everyday life; yet the data landscape for understanding COVID-19 remains limited. Public databases [Dong et al., 2020 , Smith et al., 2020 provide incoming county-level information of confirmed cases and deaths. Statisticians, epidemiologists, economists, and data scientists have used this granular data to forecast COVID-19 case-counts, deaths, and hospitalizations [Giordano et al., 2020 , Ray et al., 2020 , IHME and Murray, 2020 , Yang et al., 2020 . This paper has two main objectives. The first objective is to express reservations at the use of observed case-counts as a proxy for disease prevalence and in estimation of standard epidemiological models for inference and forecasting. The reason is straightforward: observed case-count data is plagued by selection bias and measurement error. Through a series of calculations, we will demonstrate that the information gained from increasing testing capacity is limited in the presence of selection bias and when testing inaccuracies persist. In particular, the millions of tests in the US have a small effective sample size when compared to random sampling. These calculations demonstrate the importance of probabilistic sampling designs over time for estimation of point prevalence and effective reproduction number.

Due to monetary and time constraints, however, random testing is performed infrequently. As of June 2021, Indiana and Ohio are the only states to conduct statewide random sample testing 1 .

Indiana's sample was collected from April 25-29, 2020 25-29, [Yiannoutsos et al., 2021 . Such infrequent random testing is likely to provide insufficient information to help researchers and policy makers better understand the disease trajectory which can change rapidly over time. Therefore, while random testing may be preferable in theory, in practice governments, researchers, and policy makers continue to use coronavirus case-counts to understand the impact of COVID-19 on the population and make data-informed decisions.

The second objective is to demonstrate how random samples provide necessary auxiliary information to address selection bias in coronavirus case-count data. Random samples provide the necessary covariate information from a representative sample from the population to estimate selection propensities. These propensities can then used in an inverse-probability weighting scheme to construct estimators of disease prevalence that attempt to control for selection bias. A doubly robust extension allows researchers to combine these estimates with epidemiological forecasts based on compartmental models that are common in the study of infectious diseases [Hao et al., 2020 , Ray et al., 2020 , Johndrow et al., 2020 .

The proposed approach requires covariate information to be collected on individuals who receive a COVID-19 test. Unfortunately, many states do not require or report auxiliary covariate information beyond basic demographic information (e.g., gender, age, race, and ethnicity). We end with a brief list of suggestions of changes to current practice based on the proposed methodology. While we demonstrate empirical improvements over simple disease prevalence estimates, we also highlight how selection bias may persist and impact uncertainty quantification.

1.1. Related work. This article discusses the relationship between three statistical concepts: selection bias, measurement error, and population size. While the impact of measurement error [van Smeden et al., 2019] and selection bias [Keiding and Louis, 2016] on estimation are both well-studied topics, here we provide a new perspective by building on the work of Meng [2018] who studied an error decomposition to understand the relationship between selection bias and population size.

Specifically, we quantify the interaction between measurement-error and selection bias on statistical error, showing how the sign and magnitude can change drastically.

After demonstrating the limitations of case-count analysis when compared to random sampling, we then assess whether there is potential for combining the nonprobability samples with probability samples to improve point prevalence estimation. For any probability sampling design, the Horvitz-Thompson estimator [Horvitz and Thompson, 1952] incorporates design information via inverseprobability weights (IPW). For nonprobability samples, the IPW estimator requires modelling the propensity scores. Its use in the survey context is also referred to as quasi-randomization [Elliott and Valliant, 2017] . Valliant and Dever [2011] consider a weighted logistic regression procedure using the pooled probability and nonprobability samples. Chen et al. [2019] consider a pseudo-log-likelihood approach that uses the random samples as a proxy for a term in the log-likelihood. Here, we extend this approach to account for measurement-error as well as observing random samples at multiple times. We then provide an extension of the statistical error decomposition and discuss the trade-offs inherent in such a weighting approach.

One core component of coronavirus research is epidemiological compartmental modelling of case-count and death data. These models can be used to answer a variety of research questions including case-count forecasting, estimation of the effective reproduction number, and estimation of quarantine and other health policies on infectious disease dynamics. The basic approach is a deterministic compartmental model called the susceptible-infectious-recovered (SIR) model. A probabilistic extension was proposed by Osthus et al. [2017] to model one-dimensional time series of infected proportions. extended this approach to incorporate interventions and assess interventions on COVID-19 epidemic in China. Hao et al. [2020] extends this work further to account for various presymptomatic infectiousness, time-varying ascertainment rates, transmission rates and population movements.

Given a probability sampling design, individual predictions can be leveraged to improve estimation via model-assisted approaches [Breidt and Opsomer, 2017] . For nonprobability samples, Chen et al.

[2019] derive a doubly robust approach that uses outcome predictions given covariates on the nonprobability and probability samples. Here, we combine the compartmental model of Song et al.

[2020] but instead, as in Johndrow et al. [2020] , focus on COVID-19 confirmed death count data.

We generate epidemiological forecasts for point prevalence of each population strata. We then demonstrate how to combine these forecasts with the IPW approach to construct doubly-robust estimates of point prevalence. A derived statistical error decomposition guides this discussion.

Recent work by Zhao et al. [2021] pointed out that estimation of key epidemiological parameters such as the incubation time using standard epidemiological models can suffer from severe bias due to issues beyond selection bias and measurement error. Namely, right truncation and epidemic growth leading to patients "being more likely to be infected towards the end of their exposure period" [Zhao et al., 2021, pp. 3] . Their approach carefully constructs the study sample and statistical model to account for these issues. In this paper, rather than focusing on construction of a study sample, we ask whether one can collect auxiliary information to address selection bias in the observed case count data directly.

Here we provide the necessary background to understand COVID-19 diagnostic testing, its scientific use in managing the pandemic, and the data streams considered in this manuscript.

2.1. Diagnostic testing. Upon infection with SARS-CoV-2, an incubation period starts and lasts approximately five days [Lauer et al., 2020] before the viral load is high enough to be detected. A molecular test refers to diagnostic tests that aim to detect increased viral load (e.g., RT-PCR or antigen tests). If someone has an active infection then after the incubation period, a molecular test with perfect sensitivity will yield a positive result for the next few weeks. After that, the viral load will decrease and a molecular test with perfect specificity will come back negative. While an infected individual may yield a positive molecular test for several weeks, they will likely stop transmitting the disease within a few days of infection, meaning a positive molecular test does not imply transmissibility.

A molecular test conducted on an actively infected individual may return a negative result. Such false negatives are very strongly associated with when the test is conducted. In the incubation phase, most molecular tests will return a false negative result. Molecular tests are most sensitive when the viral loads are highest which occurs during the first few days of transmissibility [Mina et al., 2020] .

Moreover, most molecular tests are performed via nasopharyngeal swab. Specimen collection by swab is known to impact false negative/positive rates regardless of test timing. Systematic reviews suggest that 87% sensitivity and 97.6% specificity are reasonable estimates for current RT-PCR tests [Arevalo-Rodriguez et al., 2020 , Woloshin et al., 2020 , Cohen et al., 2020 .

The primary goal of molecular tests is diagnosis of active infections in the population. Such diagnostic tests generate important information about the presence of SARS-CoV-2 in the population, and help scientists and policy-makers understand patterns of transmission and propagation. Rapid and frequent molecular testing is cited as a key component [Scarpetta et al., 2021] in effective strategies to identify active infections and prevent systemic outbreaks.

Publicly available data on COVID-19. The primary goal of this manuscript is to produce accurate estimates of the population-level active infection rates over time using publicly available viral testing data. Secondary goals include estimation of rates of change and the effective reproduction number which characterize disease trajectory. These quantities are fundamental to public health policy and provide critical information on the presence and transmission of SARS-CoV-2.

Coronavirus case-count data refers to the number of positive molecular tests performed on each day. Figure 5a plots the number of reported confirmed COVID-19 cases per day in the state of Indiana. Figure 5b plots the total number of COVID-19 molecular tests performed per day. Figure 5c plots the total number of COVID-19 related reported deaths per day. Public databases maintained by Johns Hopkins University and the New York Times provide accessible incoming county-level information of confirmed cases and deaths.

Public databases most often, however, only contain aggregate information. The Johns Hopkins dashboard, for example, provides demographic breakdown of case counts as well as the total confirmed cases and deaths by county. Aggregate time series of case count and deaths can also be extracted. Unfortunately, most dashboards do not provide demographic information on who requested a test nor on who tested positive for SARS-CoV-2 over time. Working closely with the State of Indiana, we were able to obtain access to COVID-19 total tests, positive tests, and related deaths per day broken out marginally by age, gender, ethnicity, and race [IDOH, 2021] . These granular datasets are now publicly available and motivate the proposed approach.

Remark 1 (Reporting Delays). Figure 5 shows clear reduced testing and case count reporting on weekends compared to weekdays. Moreover, COVID-19 tests are reported on the day they were administered, while case counts are reported based on the date the positive test was reported to and confirmed by the Indiana Department of Health system. To minimize the impact of reporting, testing and case-count data are aggregated at the weekly level for analysis. 65, diabetic, high-blood pressure, obesity, pregnancy, and minority populations at greater risk of severe illness [Adams, 2020] . On April 28th, 2020, the criteria expanded to include any Indiana resident with virus symptoms, people in close contact with those who have tested positive and residents of congregant communities [Reports, 2020] . On June 15th, 2020, ISDH lifted all restrictions and testing expanded to include anyone in Indiana who wants to be tested for coronavirus [Rudavsky, 2020] . Testing restrictions impact the propensity of an individual to receive a test and therefore, if COVID-19 positive, contribute to the case count.

In this paper, testing restrictions are addressed by fitting time-varying testing propensities that depend on relevant covariate information.

On March 23rd, 2020, Indiana's governor issued a stay at home order effective March 26th through April 5th. The order was extended until April 30th. On May 1st, 2020, a five-stage plan for gradual reopening was announced by Governon Holcomb [May, 2020] . Such policies target reduction in active infection rates. In this paper, Indiana's public health policy is incorporated in our construction of epidemiological forecasts in Section 4.2.

2.3. Probabilistic samples in Indiana. Due to testing restrictions and other potential selection biases, publicly reported COVID-19 case count data may not be sufficient to understand active infection rates or the disease trajectory. Here, we discuss two random samples that provide auxiliary information and may help address selection bias.

2.3.1. Random statewide testing. Between April 25-29, 2020, Indiana conducted statewide random molecular testing of persons ages ≥ 12 years to assess prevalence of active infection to SARS-CoV-2 [Yiannoutsos et al., 2021] . A stratified random sampling design was conducted using Indiana's 10 public health preparedness districts as sampling strata. 15,495 participants were contacted resulting in a final sample size of 3,658. Demographic data was collected (e.g., summary statistics on age, sex, and race) as well as data on whether they experienced any COVID-19 compatible symptoms during the past 2 weeks or had shared a household with someone who had a positive test result for SARS-CoV-2. During May 2-3, 2020, an additional non-random sample of 898 individuals was also collected. Table 1 summarizes the data.

2.3.2. Facebook/CMU symptom survey. Since April 2020, Facebook has started randomly showing an opt-in symptom survey to its users [Group, 2020] . Data collected includes basic demographic information and if the respondent has symptoms such as fever, coughing, shortness of breath, or loss of smell which are associated with COVID-19. The survey defines an individual as displaying COVID-like symptoms if they exhibit a fever along with a cough, or shortness of breath, or difficulty breathing. Figure 1 displays smoothed estimates of the fraction of individuals who report COVID-like symptoms within the past 24-hours by age and gender. The Facebook symptom survey is used as the main source of auxiliary information on time-varying characteristics of the population of Indiana, e.g., displaying COVID-like symptoms or in contact with COVID-19 positive individuals. Figure 1 . Rate of reported COVID-19 symptoms per strata. Daily rates were estimated using weighted method suggested by [Group, 2020] on each day separately and then smoothed over time using local-linear nonparametric regression.

We start with some simple notation. Let N denote the population size. At a given time, let Y j denote COVID-19 status for the jth individual in the population, j = 1, . . . , N . Here, like in survey methodology [Cochran, 1977] , we treat COVID-19 status as a fixed but unknown quantity of interest. For simplicity, we start by ignoring the dynamic nature of the outbreak and recoverability of individuals. We assume either individual j is COVID-19 positive and Y j = 1 or is COVID-19 negative and Y j = 0. We also let I j ∈ {0, 1} be an indicator that the individual was tested (I j = 1) or not (I j = 0).

To start, we assume the overall number of active COVID-19 cases and/or active infection rate (AIR) are of primary interest. That is, we are interested in either the population total Y = N j=1 Y j or the population averageȲ = Y /N . Suppose that n tests are performed and we observe the values y 1 , . . . , y n ∈ {0, 1}. Then a natural candidate for AIR is the proportion of positive tests y = 1 n n i=1 y i , and a natural candidate for overall active cases is N ×ȳ. Under simple random sampling (SRS) or any other epsem 2 design, the above are unbiased estimators of the population-level quantities of interest. Under SRS, the variance of the estimator can be expressed as 1

. These random selection mechanisms are independent of the outcome of interest. When this is not the case, selection effects may cause bias. To better understand this issue, Meng [2018] recently provided the following intuitive and powerful statistical decomposition of the error betweenȳ and the true proportionȲȳ

The first term represents data quality, the second data quantity, and the third problem difficulty.

The term ρ I,Y is the empirical correlation between the population values {Y j } N j=1 and the selection values {I j } N j=1 . Under simple random sampling, E I [ρ I,Y ] = 0, where the expectation is with respect to the selection mechanism I, so there is no bias. The SRS variance formula above shows that

3.1. Imperfect testing. Tests are imperfect. COVID-19 testing is no exception. Here we investigate the interplay between imperfect testing and selection bias. Researchers often assume measurement error leads to parameter attenuation. When paired with selection bias, however, the two sources become entangled, and resulting errors in magnified, muted, or even switch signs.

First we require some additional notation. Let P j be an indicator of measurement error, equal to 1 when we incorrectly measure the binary outcome and 0 when we observe the true binary outcome.

We suppose this is a stochastic variable where pr(P j = 1 | Y j = 1) =: F N is the false-negative rate and pr(P j = 1 | Y j = 0) =: F P is the false-positive rate. If individual j is selected (i.e., I j = 1) then 2 equal probability of selection method the observed outcome can be written as Y j = Y j (1 − P j ) + (1 − Y j )P j . The attentive data analyst will recognize the estimatorȳ n is now biased for simple random samples. In Appendix B.1.1, assuming sensitivity and specificity are known a priori, a novel iterative procedure is used to construct the estimatorỹ n = (ȳ n −F P )/(1−(F P +F N )), which is unbiased under simple random sampling (SRS); see Appendix B.2 for a discussion of the connection to model-based estimators. To understand the impact of selection bias and imperfect testing, we derive the following statistical decomposition of the error betweenỹ n andȲ :

where f = n/N is the sampling fraction, f 1 and f 0 are sampling fractions for COVID-19 positive and negative individuals respectively, and ∆ = f 1 − f 0 is the sampling rate differential. See Appendix B.1.1 for the derivation. This extends work by Meng [2018] to account for imperfect testing. The first three terms continue to represent data quality, data quantity, and problem difficulty respectively. The new term D M represents the imperfect testing adjustment which is a complex function of the sampling rate differential, the odds ratio, and the ratio of measurement error interaction with prevalence and sampling rates interaction with prevalence. Figure 2 shows that D M , as a function of the relative frequency (f 1 /f 0 ) and log odds ratio, can be both positive and negative as well as a range of magnitudes [Beesley et al., 2020 , Beesley and Mukherjee, 2019 , van Smeden et al., 2019 . Assuming no measurement error, D M = 1 so the relation between estimation and selection bias is simple, e.g., if COVID-19 positive individuals were more likely to receive test then this implies upward bias in prevalence estimates. Under random testing (i.e., f 0 = f 1 ), D M = (1 − F P − F N ) −1 so measurement error simply magnifies this error. When tests are imperfect and selection bias exists, this simple relationship no longer holds.

Comparing the mean-squared error (MSE) under a selection mechanism I with imperfect testing and SRS with perfect testing, we see that Figure 2 . Imperfect testing adjustment: relative frequency f 1 /f 0 (x-axis) against odds ratio (y-axis) for F P = 0.024 and F N = 0.13. Color scaled so blue = −10, white = 0, and red = 10.

implying the error relative to SRS increases as a function of population size [Meng, 2018] . That two countries with the same testing strategy can yield wildly different estimates due to population size is too often ignored in current communications of case-count data.

A key question is "What is the (effective) sample size from a SRS with perfect testing that would yield equivalent MSE to the current testing strategy?" In Appendix B.4, we show the effective sample size n ef f can be bounded by

Between [Siddarth and Weyl, 2020] have argued for increased testing capacity, which may likely reduce the relative sampling rate. Even if the relative sampling rate drops to 1.2 and f increases to 0.01 then the effective sample size will increase to 1025. Thus the effective sample size even in optimistic scenarios is equivalent to a moderate random sample from the population. Moreover, increased testing capacity may also come at the cost of increases in false positive and negative rates. Consider the case where f increasing from 0.003 to 0.01 and is associated with the false negative rate rising from 13% to 20%. Then the effective sample size is 863, representing a 5.1 factor increase rather than the expected 6.1 factor increase. See Section B.7

in the Supplementary Materials for additional effective sample size calculations.

3.2. Regrettable rates: complex biases resulting from self-selection. The prior analysis demonstrates the limited information regarding COVID-19 prevalence in observational case-count data. Scientists, however, may claim that daily observed case-counts simply undercount daily total cases by a constant multiple over time. If true then the ratio of case-counts at consecutive times may be a good estimate of the true change in prevalence, helping scientists understand the disease trajectory. We next demonstrate how selection bias and imperfect testing impact such estimates.

LetȲ t−1 andȲ t denote the prevalence on two consecutive days and consider the estimator r =ỹ t /ỹ t−1 . Using a second-order Taylor series approximation, the error betweenỹ t /ỹ t−1 and

where ρ I j ,Y j is the data quality, f j is the sampling fraction, D M j is the measurement error adjustment, and CV (Y j ) = σ Y j /Ȳ j is the coefficient of variation on day j. See Appendix B.5 for the derivation.

The error magnitude depends on the true rateȲ t /Ȳ t−1 so a large decrease will have a small error relative to a large increase. The second term represents potential cancellation which can occur when data quality, sampling fraction, measurement error, and prevalence are constant across time. Figure 3a displays the trajectory of the true ratio and the potential biased estimators under a susceptible-infected-recovered (SIR) model [Pastor-Satorras and Vespignani, 2001 , Newman, 2002 , Parshani et al., 2010 for the epidemic dynamics, with state evolution given by

where s t , i t and r t are the fraction of susceptible, infected, and removed (recovered or deceased) individuals in the population at time t respectively. In terms of bias, the rate is overestimated prior to the peak and underestimated afterwards; the bias increases dramatically when the relative fraction exceeds 2. Such biases may have a substantial impact on policy making. Overestimation pre-peak may give policy makers more leverage in proposing aggressive actions to reduce prevalence.

Underestimation post-peak puts pressure on policy makers to prematurely relax social distancing measures. Estimates at the peak time appear to have minimal bias.

3.3. Estimation of effective reproduction number. Many epidemiologists argue that tracking the effective reproduction number R t is the only way to manage through the crisis [Leung, 2020] .

Under a Poisson likelihood, a simple relation between the trajectory of new cases and the effective reproduction number can be derived [Bettencourt and Ribeiro, 2008] . In particular, under an SIR model the number of case counts on day t, denoted K t , is Poisson distributed with rate

is the number of new cases on day t − 1 and γ is the serial interval, which is approximately 7 days for COVID-19 [Sanche et al., 2020] . Using this relation, a moment-based estimator is given by

Of course, we do not observe K t and K t−1 . Under SRS of new cases among those susceptible on day t, the natural estimator is S tỹt . Unfortunately the number of susceptible individuals on day t is unknown. Here, we study the estimatorR t = 1 + 1 γ log (ỹ t /ỹ t−1 ). We can again express the statistical error ofR t − R t in useful terms as follows

This implies a similar trade-off as before but on the logarithmic scale. The error is no longer scaled byȲ t /Ȳ t−1 but by the serial interval and does not depend on prevalence but on the fraction of new cases out of those susceptible. This leads to differences in when the bias is most pronounced. Here, for simplicity, we focus on comparing the estimated effective reproductive rate. We assume the two time-series are aligned so that t = 0 is the time of first case in each population respectively.

Consider two countries (A and B) in which the peak occurs 2 weeks prior for country A than country B. Figure 4 presents such a comparison where each country's disease trajectory follows an SIR model (A=black and B=grey). Figure 4b shows how biases interact in complex ways. At first, the difference is correctly estimated; then the gap is over-estimated as country A sees a rapid rise in cases; then the magnitude of over-estimation increases as country A sees declining case-count while country B sees rapidly increasing case-count; then country A's rate is correctly estimated while country B's rate is under-estimated as it sees declining case-count; finally, the gap disappears.

While this may not always be the case, the analysis demonstrates how estimates can tell a more complex story than the truth (i.e., country A's peak is 2 weeks prior to country B's peak). 

The prior section presented negative consequences of selection-bias and measurement error when estimating infection prevalence, rates of change, and the effective reproduction number from observed case-count data. In this section, we consider two directions to improve upon these estimators. The proposed methods and statistical error decompositions guide our recommendations in Section 6.

4.1. Selection propensity estimation. With non-probability samples, bias can be reduced by modelling the self-selection propensity and using inverse probability weighting (IPW) [Elliott and Valliant, 2017] to adjust for selection bias. In the current context, however, one does not observe those who are not tested. To estimate selection propensities, auxiliary information is needed.

To see this mathematically, let X j denote a vector of covariates for the jth individual in the population, j = 1, . . . , N . For simplicity, the dynamic nature of the outbreak and recoverability of individuals is ignored for now. Suppose the selection indicator I j is a Bernoulli random variable that depends only on these covariates, i.e., P (I j = 1 | X j = x) = π(x; θ). Here, we focus on logistic regression models, i.e., π(x; θ) = expit x θ . Maximum likelihood estimation follows by maximizing

The first sum only involves individuals observed in the nonprobability sample. The second sum is over the entire population. Maximum likelihood estimation therefore requires knowledge of covariate information for every individual in the population. Typically, this is not possible. Here we present a method that uses auxiliary information obtained from probability samples.

4.1.1. Auxiliary information through probability samples. Here we assume access to a probability sample measuring the same set of covariates. LetĨ j be an indicator that the individual was included in the probability sample andW j be the probability of inclusion for the jth individual. Chen et al.

[2019] use a probability sample to construct a design-unbiased estimator of the second term

Expectation of 4.2 with respect to the sampling design yields (4.1). Solving (4.2) is done by iteratively re-weighted least squares (IRLS); see Section F in the supplementary materials for details.

4.1.

2. An IPW estimator and statistical error decomposition. Given a selection propensity, define the inverse probability weight w(x) = π(x;θ) −1 . Then the IPW estimator adjusted for measurement error is given by

where equality (2) is under the assumption that x i is a stratification variable with k indexing the strata, w k is the weight and d k is the number of samples in strata k, and w = K k=1 d k w k . LetĨ j (X j ) = I j · W (X j ) for j = 1, . . . , N . Then the error when comparing weighted estimatorȳ n to the true prevalenceȲ can be expressed as:

Comparing (4.4) to (3.1) shows that weighting impacts the estimation error in three ways. First, there is a negative impact on the data quantity component; taking the ratio of these quantities

Hence, if the data quality does not increase (i.e., |ρĨ (X),Y | = |ρ I,Y | ) then weighting increases the error magnitude. Second, the relative error increase depends on the fraction of population sampled f , implying that for large samples there is a larger potential increase in the error if the weights do not improve data quality. Third, the impact of measurement-error on data quality is changed when considering a weighted estimand. In particular, weighting may result in sgn(∆) = sgn(∆) which implies the impact of measurement-error may be in a different direction.

As demonstrated below in Lemma 4.1, if the propensity model is correctly specified then the E R [ρĨ (X),Y ] = 0 and therefore ρĨ (X),Y = O(N −1 ); however, if the weights are not correctly specified then the data quality index is unlikely to inversely scale with population size. Similar to Meng [2018] , if the data quality is not at the level of N −1 , then confidence intervals constructed from an IPW estimator are likely to put too much confidence in the sheer data size.

Here we extend the IPW approach to the temporal setting to account for the dynamic nature of the outbreak by considering the joint likelihood

where t = 1, . . . , T are the days when case-count data is reported. Here, I j,t denotes self-selection into testing on day t, which is highly correlated with prior testing and results. For example, an individual who tests positive may be unlikely to seek testing in the subsequent few days/weeks.

Moreover, an individual in a high prevalence area may be more likely to seek out testing. Here, we assume that the covariate vector X j,t contains all features of the past relevant for selection.

If sufficiently large random samples are collected at each time t = 1, . . . , T , then the pseudolikelihood can be re-written as in (4.2) and propensities estimated separately per time point.

Unfortunately, large probabilistic samples are not available at every time within a given region. To address this, here we consider a non-parametric kernel-based approach where the selection propensity at time t, denotedθ t , maximizes the smoothed pseudo-likelihood

where K h is a kernel function with tunable parameter h. Given π(x;θ t ), the prevalence estimator y n,t is given by 4.3 using case-count data observed on day t.

Here we suppose there is a sequence of finite populations of size N ν indexed by ν and that there are L ν non-probability samples and probability samples of size n drawn at equally spaced times {t l } Lν l=1 over the study window [0, T ]. Assuming correct selection model specification, then under the probability sample design and nonprobability sample propensities, Lemma 4.1 shows that the IPW estimator at a time t ∈ {t l } is consistent as ν goes to infinity (i.e., N ν , L ν → ∞) and calculates the estimator's variance. In Lemma 4.1, sensitivity/specificity are unknown and estimated using a pseudo-likelihood on two random samples whose sizes (denoted n F P and n F N ) reflect uncertainty in these quantities. See Appendix E for additional details.

Lemma 4.1 (Variance of IPW estimator). The estimatesμ t :=ȳ n,t ,π j,t ,F P , andF N at a time t ∈ {t l } are solutions to the following set of estimating equations

where η t = (µ t , π t , F P, F N ). Under certain regularity assumptions (see Appendix E), we havē y n,t −Ȳ t = O p (n −1/2 ) and var(ŷ n,t ) = V

and Var(·) are under the joint randomization of propensity score and sampling designs.

Model-based estimation. Up to this point, the primary focus has been selection bias in coronavirus case-count data from a survey sampling perspective. Here, we consider compartmental model approaches from infectious disease epidemiology. Our primary objective is a model-based forecast of strata-level prevalenceȳ k . To do this, a probabilistic extension of a standard epidemiological state-space model -the susceptible, exposed, infected, and removed (recovered and death) model, or SEIR model -is presented. A probabilistic SIR model was originally proposed by Osthus et al. [2017] with only one-dimensional time series of infected proportions; this formulation was extended by Song et al.

[2020] to model coronavirus case-counts.

Let s t , e t , i t , and r t denote the proportion of survivors, exposed, infected, and removed cases (i.e., including both recovered cases and deaths) at time t. The population-level SEIR dynamics are then given by the following set of differential equations:

Here, we consider covariate information that takes the form of a stratification variable with K strata.

Let I k,t to denote the number of new infections on day t in the kth strata. The joint distribution of strata-specific new infection totals follows a multinomial distribution with (I 1,t , . . . , I K,t ) ∼ Multinomial (I t , (p 1,t , . . . , p K,t )) .

where (p t ) T t=1 = ((p 1,t , . . . , p K,t )) T t=1 are a sequence of parameters on the simplex, i.e., K k=1 p k,t = 1. Selection bias is addressed by analyzing COVID-19 death data rather than case counts. Let D k,r denote the number of individuals who pass away on day r from strata k. Then

where IFR k is the infection fatality rate for the kth strata and θ j is a discrete-time distribution for time from infection to death. This extends prior analysis of death data Johndrow et al. [2020] by allowing the infection fatality rate to depend on a stratification variable, which is important as IFR depends heavily on age [Levin et al., 2020] . See Section 5.2 for discussion of parameter choices. 4.3. Doubly robust estimation. Rather than relying solely on IPW or epidemiological forecasts, here we combine forecasting and inverse-probability weighting by extending recent work by Chen et al. [2019] to account time-varying propensities and measurement-error. In this context, the doubly-robust estimator is given bȳ

whereμ(x j ) is not corrected for measurement-error as it estimates true case counts. This estimator is called "doubly-robust" because it is consistent if either the model-based forecasts or the time-varying propensities are correctly specified. A statistical error decomposition can be derived

(4.7)

See Appendix D for the derivation. If the model is adequate, then one may expect a reduction in the problem difficulty and (potentially) in the data quality components. Interestingly, the impact of measurement-error on data quality now depends on a relative comparison of the data quality and problem difficulty of the weighted estimator and the doubly-robust estimator.

Unfortunately, the first term of the doubly robust estimator cannot be computed as covariate information is not collected on the entire population. Here, we suppose the same asymptotic regime as in Section 4.1.4 and use the probability sample at the time t ∈ {t l } to estimate this term:

Assuming correct selection propensity model specification, then under the probability sample design and nonprobability sample design, Lemma 4.2 shows that the doubly robust estimator is consistent and calculates the estimator's variance. See Appendix E for additional details.

Lemma 4.2 (Variance of doubly-robust estimator). The estimates µ t :=ȳ n,t andπ j,t are solutions to the following set of estimating equations where η t = (µ t , π t , F P, F N ). Under regularity assumptions (see Appendix E), we haveȳ n,t −Ȳ t = O p (n −1/2 ) and var(ŷ n,t ) = V

and Var(·) are under the joint randomization of propensity score and sampling designs.

We next consider estimation of the active infection rate in Indiana using unweighted, IPW, model-based, and doubly robust estimates. To start, we recap the data sources used in estimation:

• Testing data: The number of daily tests performed and number of daily positive tests are reported. These counts are broken out jointly by age, gender, and racial demographic information. Figure 5a and 5b plots daily COVID-19 positive cases and tests by age strata.

• Random/Nonrandom statewide sample: Table 1 summarizes data from a random sample from April 25-29th as well as a nonrandom sample obtained between May 2-3 in racial/ethnic minority communities [Yiannoutsos et al., 2021] . The nonrandom sample is not a random subsample of the overall case-counts; however, this data provides important supplementary covariate information. To account for the nonrandom sample being from high risk areas, we adjust estimates to match the statewide positivity rate of 11.7% on August 30th. These adjusted rates are presented in parentheses in Table 1 along with the relevant covariate information.

• Facebook symptom survey: From the daily symptom surveys completed on Facebook (see Section 2.3.2 for details), we extract survey responses for individuals who identify as living in Indiana. We collect age, sex, and demographic information as well as COVID-19 related symptoms, which Facebook defines as having (1) a fever and cough, (2) shortness of breath, or (3) difficulty breathing. Table 3 in Section G of the supplementary materials shows minimal bias with respect to symptom distributions when comparing to Indiana's random sample to the Facebook symptom survey data collected from April 25th to April 29th.

• Death data: Daily COVID-19 related deaths are observed by age, gender, and racial demographics. Figure 5c plots COVID-19 related deaths over time by age group. While most tests and positive cases are within the younger age strata, most deaths are within the 70+ age strata. Using the constructed weights and the adjusted strata-level prevalence estimates, the IPW estimate under no measurement-error is 7.7%, a decrease of four percentage points from the observed prevalence of 11.7%. We also make use of Facebook's symptom survey over that window of time to construct a second IPW estimate conditional on demographics and fever but ignoring the household and prior testing information, which under no measurement-error is 6.5%.

The Indiana study did not report sensitivity and specificity; therefore, we take the suggested tests that had already performed yields a sampling fraction of f = 2.96 × 10 −3 . Here we consider estimation of data quality E I ρĨ (X),Y . In Meng [2018] , estimation relied on observing the true outcome (i.e., election vote totals). Here, we use the random sample which estimates the true prevalence of active COVID-19 disease at 1.81% Yiannoutsos et al. [2021] . Our goal is to build sensitivity analyses to understand the amount of information in observational case-count data.

The unweighted estimate for the true prevalence of active COVID-19 disease between April 25th

and April 29th is 11.7%. Assuming a false negative rate of 13% and false positive rate of 2.4%, the unweighted estimate is 11.0%, leading to an error of 9.2%. Using (3.1), an estimate of the relative sampling rate is

The IPW estimates for the prevalence of active COVID-19 disease between April 25th and April 29th adjusted for measurement-error are 6.2% and 4.9%, leading to errors 4.4% and 3.1% respectively.

Using (4.4), an estimate of the relative sampling rate is

= 8.14 × 10 −3 ⇒∆ = 8.22 × 10 −3 ⇒M = 3.9, using the Indiana non-random sample. For the IPW estimate using Facebook data,M = 3.3.

Therefore, bias is high using unweighted data and remains moderate using the weighted estimates.

A sensitivity analysis can be performed by considering the range of false negative/positive rates.

Here, sensitivity ranges between 81% and 91% and specificity between 95% and 98.8% Katz et al.

[2020]. This leads to a range for M of (5.60, 6.44) for the unweighted analysis, and (3.63, 4.07) and

(3.10, 3.45) for the weighted analyses.

The IPW analysis is next extended to the time-varying setting.

To do so, we make use of the Facebook symptom survey, hospitalization, and testing data. Recall the COVID-19 testing and positive case counts are known by age, gender, and racial demographics.

Symptom status (e.g., fever, coughing, shortness of breath) and related covariate information (COVID-19 positive contact), however, are currently unavailable 3 . As COVID-19 symptom status is likely to alter the testing propensity and likelihood of active infection, for illustrative purposes Facebook symptom survey and hospitalization data are used in two ways to impute symptom status per strata. We outline the imputation methods below; see Section 6 for additional discussion.

In the first approach, we estimate two logistic regressions using weighted pseudo-likelihoods with the Facebook survey symptom data. The first estimates the probability of contact with a COVID-19 positive individual given demographic and COVID-19 test status (positive or negative COVID-19 test). Figure 9a and 9b in Section G in the supplementary materials presents the estimated likelihood of contact with a COVID-19 positive individual given a negative and positive COVID-19 test in the past 24 hours respectively. The second estimates the probability of fever given demographic, COVID-19 test status, and whether the individual has had contact with a COVID-19 positive individual. Figure 10a and 10b in Section G in the supplementary materials presents the estimated likelihood of reporting a fever with a COVID-19 positive individual given a negative and positive COVID-19 test in the past 24 hours respectively. We see that likelihood of fever varies greatly based on whether the individual also reported contact with a COVID-19 positive individual. Using these 3 Whether this is due to data privacy considerations or lack of data collection efforts is unclear.

two models, mean imputation is used to calculate the number of positive and negative tests given demographic strata, fever status, and COVID-19 contact status. Inverse probability weights are computed based on the resulting dataset (termed IPW1). In the second approach, we leverage hospitalization information. We first estimate the probability of fever given demographic and COVID-19 test status. When the COVID-19 test status is positive, the probability of fever is allowed to depend on whether the individual was hospitalized. Figure 12a and 12b in Section G in the supplementary materials presents the estimated likelihood of reporting a fever with a COVID-19 positive individual given a negative and positive COVID-19 test in the past 24 hours respectively. We see that hospitalization significantly increases the likelihood of fever as expected. We use these models and the case-to-hospitalization rates by demographic strata to perform mean imputation of the number of positive and negative tests given demographic strata, fever status, and COVID-19 contact status. Inverse probability weights are then computed based on the resulting dataset (termed IPW2). Figure 6 presents the testing propensity for non-Hispanic, white males across age strata and fever status using the second approach. Note that the ratio of testing propensity within strata across fever status is time-varying, starting 50 times more likely in early April and dropping to ten times more likely by end of 2020.

Here we consider the multinomial SEIR model using observed death data as presented in Figure 5c . Table 2 . IFR by age-strata discretized version of a truncated normal distribution with mean 25, standard deviation 5, minimum value 0, and maximum value 44. This closely mirrors the distribution from Johndrow et al. [2020] .

Strata for ages less than 40 are collapsed due to the limited number of COVID-19 related deaths in this age range. For similar reasons, the multinomial parameter p t is assumed to be constant in time with a Dirichlet prior.

The SEIR model in equation (4.6) is extended to allow for time-varying transmission rates β t to account for public policy changes discussed in Section 2.2.1 over the time period considered. Here, we insert three change points (t 1 , t 2 , t 3 ) on March 23rd, June 15th, and October 1st of 2020 respectively. Given sensitivity to these choices, instead of considering a simple multiplicative structure, we allow for delayed implementation and slow change in the transmission rate by using weights:

where (β 0 , β 1 , β 2 , β 3 ) is the vector of transmission rate parameters, ν ≥ 0 is the potential delay, ξ is the rate of change, and 1[·] is an indicator function. Each weight w (k) t = 0 for t < t k and w (k) t → 1 as t → ∞. See Section H in the supplementary materials for details on prior specification.

To check model fit, a posterior predictive check on aggregate death counts was performed. Figure 7a shows the results which suggests chosen SEIR model fits the observed data well. Figure 7b presents the posterior distribution of total new cases. Figure 14 in the supplementary materials computes the weekly undercount factor of observed case counts. Posterior distributions for the age-specific case counts are used as part of the doubly-robust estimator of the active infection rate.

Here, we construct active infection rate estimates using the unweighted, inverse-probability weighted, model-based, and doubly robust estimators. Figure 8 presents the results. The inverse-probability weighting methods does reduce bias compared to the unweighted estimates. Bias, however, does remain which we conjecture is due to the limited availability of symptom and other important covariate information to estimate strata-specific infection rates. This suggests better data collection in the future may strongly improve performance.

While the model-based estimates appear more reasonable outside the summer months, note that the estimate on the last week of April is 0.30% which is a severe underestimate compared to the estimated prevalence using the stratified random sample of 1.81%. Caution is therefore warranted when interpreting these estimates. Infection fatality rates are likely time-varying and may vary by other factors such as quality of healthcare. Therefore, improvements could be made by using more accurate IFR estimates, but there is currently minimal publicly available data to do so. Moreover, the (thankfully) low number of deaths per strata make uncertainty in these estimates quite high.

Finally, the doubly robust estimate appears similar to the IPW estimate. 

There is nothing routine about COVID-19, including the corresponding statistical questions. The goal of this paper was to point out questionable statistical routines. Precision in reported case-count data gives the illusion of information when what what is needed is quantification of uncertainty.

Extensions of recent statistical error decompositions [Meng, 2018] demonstrate how selection bias leads data analysts to feel certain about incorrect conclusions. As case-count data is routinely used for public health policy making, we presented an inverse-probability weighting method and a doubly-robust estimation method that leverage auxiliary information collected through random samples to overcome these issues. We end with a brief discussion of important related topics.

Data quantity versus quality. Governments and policy makers often implicitly argue that increased testing capacity will alleviate selection bias. Without complete compliance, however, our understanding of future outbreaks may be plagued by self-selection bias, compounded by changing sensitivity and specificity rates of RT-PCR testing. Random testing removes these effect modifiers, giving governments more information to fight the disease. This paper emphasizes that data quantity is secondary to both data quality and methodological considerations to account for selection bias.

Model-based solutions. A common argument is that the SEIR model can be extended to account for selection bias and measurement error directly; therefore, there is no need for auxiliary random sampling. Without strong assumptions on the selection mechanism, however, the estimates are often not identifiable. When an issue "cannot be resolved nonparametrically then it is usually dangerous to resolve it parametrically" [Cox and Hinkley, 1974] . Absent some type of random sampling, the best route forward for all data analyses is careful associated sensitivity analyses and humility in data-driven conclusions. Irons and Raftery [2021], for example, use the Indiana seroprevalence random survey and to anchor their analysis; however, infrequent random surveys imply time-varying aspects such as the IFR may not be resolved by use of a single anchor.

Real-world implementation of the proposed method. The proposed methodology relied on access to two critical datasets: (1) COVID-19 testing, case, hospitalization, and death data by demographic strata and (2) Facebook symptom survey. Public access to (1) required submission of data requests to the state of Indiana. The author's request was one of only five data requests to be approved by Indiana for public release. Most states do not release such granular data, making selection bias adjustments difficult. Coordinated, systematic data collection and reporting is critical.

Lack of covariate information on individuals seeking COVID-19 tests is unacceptable. Random samples over time to supplement this data with auxiliary information is desperately needed. We acknowledge that this proposal will lead to data privacy concenrs that will need to be addressed.

A valid criticism of the proposed approach is that recording covariates on every tested individual is time-consuming and costly. We argue that the list of relevant factors is of reasonable length. For example, symptom status and COVID-19 contact are clearly relevant factors in testing selection.

Future work may consider how to include/exclude factors over time that are not significant to limit citizen reporting burden. Moreover, equation (4.2) presupposes covariate information is collected for all individuals in the nonprobability sample, which is often not feasible for state/local governments where rapid sample collection is prioritized. One can easily extend (4.2) by randomly sampling a subset of the nonprobability sample on which to collect the covariate information. This would balance goals of rapid testing and auxiliary data collection. All relevant code can be found at https://github.com/wdempsey/covid-umich.

Recall that P j is an indicator of measurement error, equal to 1 when we incorrectly measure the outcome and 0 when we observe the true outcome. We suppose this is a stochastic variable where pr(P j = 1 | Y j = 1) =: F N is the false-negative rate and pr(P j = 1 | Y j = 0) =: F P is the false-positive rate. If individual j is selected (i.e., I j = 1) then the observed outcome can be written

B.1. Derivations for imperfect testing framework. We start by considering the empirical mean estimator under imperfect testing, 

where now the "data defect" and "problem difficulty" are with respect to P Z rather than Y . The final term is equal to

Combining these yields:

Derivation of an estimator unbiased under SRS. We see the final term is given by F P (1 − Y ) − F NȲ is the bias associated with using the unadjusted prevalence estimateȳ n . This motivates an adjusted estimatẽ y (0) n =ȳ n − F P (1 −ȳ n ) + F Nȳ n =ȳ n (1 + F N + F P ) − F P.

Now considering the error for the adjusted estimate,ỹ

n −Ȳ , we havē

The final term is a (smaller) bias term and so we propose another adjusted estimatorỹ

This motivates recursively defining estimatorsỹ 

We can then get an estimator with no residual bias term by taking the limit as t goes to infinity; that is, defineỹ

Then the associated errorỹ n −Ȳ can be expressed as Ψ 1−(F N +F P ) .

Model-based derivation of the estimator. The estimatorỹ was derived as a limit of a process that removes the residual bias term at each step. Here we consider a model-based explanation.

Let θ = pr(Y = 1) and φ = pr(test is positive). Given a known false negative (FN) and false positive (FP) rates, we have

Thus, the estimatorỹ is also the appropriate estimator under a model-based approach. While the derivation here is more straightforward, the derivation in the prior section provides a simple formula for the associated errorỹ n −Ȳ and gives a novel connection between the empirical estimatorȳ n and the adjusted estimatorỹ n without reference to the model-based approach.

B.3. Further simplification. For the binary outcome Y , we have σ Y = Ȳ (1 −Ȳ ) . Moreover,

Then the formula for the error is given by:

By definition, we have ρ I,P Z = C(I, P Z)

We can then re-write ρ I,Y σ Y + ρ I,P Z σ P Z as

Inserting into equation (B.1) yields the desired result.

B.4. Derivation of effective sample size. Let S 2 Y = (N − 1) −1 N j=1 (Y j −Ȳ ) 2 be the population variance as defined in survey sampling [Cochran, 1977] . Then σ 2 Y = (N − 1)/N · S 2 Y . Under SRS, the MSE is the variance as the estimate is unbiased and the variance is given by (1 − f )/nS 2 Y . Then setting the MSE under general selection and SRS equal we have

Then if n ef f ≥ 1, we have that

.5. Ratio estimator. Let u = (u t−1 , u t ) ∈ R 2 and g(u) = ut u t−1 , i.e., a differentiable function g : R 2 → R. Centering a Taylor series expansion of second-order around coordinates (

where the second equality is obtained by plugging in the statistical decomposition of the error for both time points and the coefficient of variation being defined as CV (Y ) := σ Y /µ Y . Under measurement error, the extra terms D t and D t−1 can be inserted in the correct locations.

B.6. Estimation of effective reproduction number. Let

Then the previous sections derivation shows that the estimate of the number of new cases on day t is given by

Then

Computing the effective sample size. For binary outcomes, we have For binary outcomes, we have

Appendix C. IPW statistical error decomposition derivation

We start by considering the empirical weighted mean estimator under imperfect testing,

where now the "data defect" and "problem difficulty" are with respect to P Z rather than Y . The final term is equal to

Combining these yields:

By previous arguments, we have

We can then re-write ρĨ (X),Y σ Y + ρĨ (X),P Z σ P Z as

Thus yielding the desired result.

Appendix D. Doubly robust statistical error decomposition derivation

We start by considering the empirical weighted mean estimator under imperfect testing,

Appendix E. Asymptotic derivations

Here, we take the suggested measures from Arevalo-Rodriguez et al. [2020] which report 87% sensitivity is a reasonable estimates and Cohen et al.

[2020] which report 97.6% specificity. This corresponds to a false negative rate of 13% and false positive rate of 2.4%. To allow for potential uncertainty, we assume two synthetic simple random samples. The first is a simple random sample of true negative cases denoted S F P ; the second is simple random sample of true positive cases denoted S F N . As µ t and θ t are estimated independently at each time t, we can focus on the estimating equations per time point t separately.

Suppose there is a sequence of finite populations of size N ν indexed by ν. Each finite population has L ν non-probability samples and probability samples of fixed size n drawn at equally spaced times {t l } L l=1 over the study window [0, T ]. Let ∆ ν denote the gap times between consecutive sample times such that as ν → ∞ we have that ∆ ν → 0. Finally, let n F P and n F N denote the sample sizes of S F P and S F N respectively. For simplicity, dependency on ν is suppressed and the limiting process is represented by N → ∞. The asymptotic argument below relies on regularity conditions C1-C6 from Chen et al. [2019] , smoothness of the population-level distribution of the time-varying covariates {X j,t } as a function of t > 0, and smoothness of the propensity function π(x; θ) as a function of x ∈ R p .

For each ν and t, the estimates of η = (µ t , θ t , F P, F N ) are given by:

where π j,t = π(X j,t ; θ t ), Z j is an indicator of a false positive in the sample S F P andZ j is an indicator of a false negative in the sample S F N . We assume the |S F P | −1 j∈S F P Z j = 0.024 and |S F P | −1 j∈S F P Z j = 0.30. Sample sizes, denoted n F P and n F N respectively, are chosen to achieve desired estimator variance, i.e., 0.024·(0.976) n F P = σ 2 F P and 0.13·0.87

In this paper, we set σ 2 F P = 0.02 2 and σ 2 F N = 0.05 2 which means n F P ≈ 59 and n F N ≈ 45 respectively.

To prove consistency, first consider the setting where a single random sample of size n is observed at time t. LetΦ(η) denote the corresponding estimating equations, which is the same as Φ(η) except for the second component which is now given by

Then under joint randomization of propensity score model and sampling designs, we have E[Φ(η 0 )] = 0. Consistency then follows by arguments in Section 3.2 of Tsiatis (2006). Under conditions C1-C6

from Chen et al. [2019] and as n increases, we haveΦ(η ) = 0 andΦ(η 0 ) = O p (n −1/2 ) whereη here refers to the solution toΦ(η).

To prove consistency under the sequence of sampling regimes, we need to show that E[Φ(η 0 )] → 0 as N → ∞. First, we study the difference in the 2nd term:

K h,l π j,t l X j,t l ,

is the normalized kernel for shorthand. The difference in the 1st term is similarly defined.

Let X j,t,l denote the lth component of the vector X j,t . Then consider the population-level distribution {X j,t,l } N j=1 . We make the additional assumption that

That is, the limiting distributions are continuous as a function of t. If π(x; θ) is a continuous function in x and under suitable conditions on the kernel density K hν (·) with the bandwidth h ν → ∞ such that L l=1 K hν (|t − t l |) → ∞ as ν → ∞, we have L l=1 K h,l π(X j,t l ; θ) − π(X j,t ; θ) → 0

Combining this, E Φ(η 0 ) −Φ(η 0 ) → 0 which implies consistency as desired.

Then by a first-order Taylor expansion we haveη

where the expectation is with respect to the random

. This matrix can be written as a diagonal matrix equal to the diagonal of ∂Φ n (η)/∂η and then a rank-three matrix that is zero except for the first row on the off-diagonal. Let A + B denote the sum broken into these 2 components. Then Woodbury matrix identity gives us

In particular, the resulting inverse is of the form

where b 1 , b 2 , and b 3 can be calculated using the Woodbury identity.

Next, note that Var(Φ(η)) can be decomposed into A 1,t + A 2,t + A 3,t + A 4,t

By independence of these components, the variance can be calculated by summation over variance of each term individually yielding. First, V 1,t

(1−π j,t ) π j,t (Yj,t − F P − (1 − F P − F N )µj,t) 2 t K t,t (1 − π j,t )ζ t ,j X j,t 0 0 t K t,t (1 − π j,t )ζ t ,j Xj,t t K t,t π j,t (1 − π j,t )Xj,tX j,t 0 0 0 0 0 0

and V 2,t is a block-diagonal matrix with only one non-zero block that is equal to D j,t = N −2 t K 2 t,t V p n i=1W i,t Ĩ i,t π j,t X j,t which is the design-based variance-covariance matrix under the probability sampling design; and

The asymptotic variance for the IPW estimator is then the first diagonal element of the matrix

j,t Ĩ j,t π t (X j,t ; θ) 1 − π t (X j,t ; θ) X j,t X j,t Then the Fisher scoring method sets

Appendix G. Indiana COVID-19 Analysis: Additional details Figure 9a and 9b plots the likelihood for 25-34 years old given a negative test and positive test respectfully. We see that the likelihood of COVID-19 is much higher for those with a positive test and the likelihood is time-varying.

(a) Contact Likelihood Given Negative Test (b) Contact Likelihood Given Positive Test Figure 9 . Likelihood of COVID-19 contact

We then use the pseudo-likelihood to compute the likelihood of fever given age, gender, COVID-19 contact status and test result. Figure 10a and 10b plots the likelihood for 35-44 year olds given a negative test and positive test respectfully. We see that the likelihood of fever depends heavily on whether they had a COVID-19 contact and their test results. Again, the likelihood is time-varying for most configurations. Based on mean-imputation of COVID-19 contact and fever indicators, we can use the proposed pseudo-likelihood approach to compute the likelihood of getting tested for COVID-19 given age, ethnicity, race, gender, fever status, and COVID-19 contact indicator. Figure 11a and 11b plots the likelihood of testing given fever and COVID-19 contact and no fever nor COVID-19 contact respectfully. We see that the likelihood is time-varying and depends heavily on both fever and COVID-19 contact indicators.

(a) Testing Likelihood Given Fever and COVID-19 Contact (b) Testing Propensity Figure 11 . Testing Likelihood Given no Fever nor COVID-19 Contact G.2. Model 2 (Hospitalization). This model uses hospitalization records to try and improve our mean-imputation strategy. First, we use the pseudo-likelihood to compute the likelihood of fever given age, gender, and test result. The model only depends on hospitalization status for positive tests. Figure 12a and 12b plots the likelihood for 35-44 years old given a negative test and positive test respectfully. We see that the likelihood of fever is time-varying. For a negative test, the likelihood of ever fever is very high in early April, which accounts for testing restrictions. We see that hospitalization significantly increases the risk of fever given a positive test. Based on mean-imputation of COVID-19 fever using hospitalization records indicators, we can use the proposed pseudo-likelihood approach to compute the likelihood of getting tested for COVID-19

given age, ethnicity, race, gender, and fever status. Figure 6a and 6a in Section 5.1.2 of the manuscript plots the likelihood of testing given fever and no fever respectfully for all age ranges.

We see that the likelihood is time-varying and depends heavily on both fever status. For simplicity, we list the priors used in STAN below:

• beta ∼ Normal(1.5, 1) T[0,];

• gamma ∼ normal(0.3, 0.5) T[0,];

• sigma ∼ normal(0.4, 0.5) T[0,];

• phi inv ∼ exponential(5);

• i0 ∼ normal(0, 10);

• e0 ∼ normal(0, 10);

• eta ∼ normal(1, 1) T[0,];

• eta two ∼ normal(1, 1) T[0,];

• eta three ∼ normal(1, 1) T[0,];

• nu ∼ exponential(1./5);

• nu two ∼ exponential(1./5);

• nu three ∼ exponential(1./5);

• xi raw ∼ beta(1, 1);

• phi = 1/phi inv;

• xi = xi raw + 0. Figure 14 below is a plot of undercount based on the SEIR model. We see the undercount goes away by January; however, this points to potential misspecification of the IFR. 

Coronavirus testing in indiana: Here's who can get a test

False-negative results of initial rt-pcr assays for covid-19: A systematic review

An analytic framework for exploring sampling and observation process biases in genome and phenome-wide association studies using electronic health records

Statistical inference for association studies using electronic health records: handling both selection bias and outcome misclassification. medRxiv

Real time bayesian estimation of the epidemic potential of emerging infectious diseases

Model-assisted survey estimation with modern prediction techniques

Doubly robust inference with nonprobability survey samples

Sampling Techniques

Diagnosing covid-19 infection: the danger of over-reliance on positive test results. medRxiv

Theoretical Statistics

An interactive web-based dashboard to track covid-19 in real time

Inference for nonprobability samples

Modelling the covid-19 epidemic and implementation of population-wide interventions in italy

Covid symptom survey

Reconstruction of the full transmission dynamics of covid-19 in wuhan

A generalization of sampling without replacement from a finite universe

Forecasting the impact of the first wave of the covid-19 pandemic on hospital demand and deaths for the usa and european economic area countries. medRxiv

Estimating sars-cov-2 infections from deaths, confirmed cases, tests, and random surveys

Estimating the number of sars-cov-2 infections and the impact of social distancing in the united states

False-positive reverse transcriptase polymerase chain reaction screening for sars-cov-2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications

Perils and potentials of self-selected entry to epidemiological studies and surveys

The incubation period of coronavirus disease 2019 (covid-19) from publicly reported confirmed cases: Estimation and application

Lockdown can't last forever. here's how to lift it

Assessing the age specificity of infection fatality rates for covid-19: Systematic review, meta-analysis, and public policy implications. medRxiv

Each of indiana's reopening stages

Statistical paradises and paradoxes in big data (i): Law of large populations, big data paradox, and the 2016 us presidential election

Rethinking covid-19 test sensitivity -a strategy for containment

Spread of epidemic disease on networks

Forecasting seasonal influenza with a state-space sir model

Epidemic threshold for the sis model on random networks

Epidemic spreading in scale-free networks

Predictions, role of interventions and effects of a historic national lockdown in india's response to the covid-19 pandemic: data science call to arms. medRxiv

Indiana opens up covid-19 testing to all hoosiers with symptoms

Want a coronavirus test? anyone can get one now, state says. here's how

High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis

Why we must test millions a day. COVID-19 Rapid Response Impact Initiative

Coronavirus in the us

An epidemiological forecast model and software assessing interventions on covid-19 epidemic in china. medRxiv

Estimating propensity adjustments for volunteer web surveys

Reflection on modern methods: five myths about measurement error in epidemiological research

Evolving epidemiology and impact of non-pharmaceutical interventions on the outbreak of coronavirus disease 2019 in wuhan

False negative tests for sars-cov-2 infectionchallenges and implications

The term in parentheses can be re-expressed using the previous technique as: